Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder; it is the most common cause of dementia and has no treatment. It is characterized by two pathological hallmarks, the extracellular deposits of amyloid beta (Aβ) and the intraneuronal deposits of Neurofibrillary tangles (NFTs). Yet...

Full description

Bibliographic Details
Main Authors: Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, Andrew B. Roberts, Ruchika Raj, Euitaek Yang, Amal Kaddoumi
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/18/10572
_version_ 1797487236678156288
author Nour F. Al-Ghraiybah
Junwei Wang
Amer E. Alkhalifa
Andrew B. Roberts
Ruchika Raj
Euitaek Yang
Amal Kaddoumi
author_facet Nour F. Al-Ghraiybah
Junwei Wang
Amer E. Alkhalifa
Andrew B. Roberts
Ruchika Raj
Euitaek Yang
Amal Kaddoumi
author_sort Nour F. Al-Ghraiybah
collection DOAJ
description Alzheimer’s disease (AD) is a progressive neurodegenerative disorder; it is the most common cause of dementia and has no treatment. It is characterized by two pathological hallmarks, the extracellular deposits of amyloid beta (Aβ) and the intraneuronal deposits of Neurofibrillary tangles (NFTs). Yet, those two hallmarks do not explain the full pathology seen with AD, suggesting the involvement of other mechanisms. Neuroinflammation could offer another explanation for the progression of the disease. This review provides an overview of recent advances on the role of the immune cells’ microglia and astrocytes in neuroinflammation. In AD, microglia and astrocytes become reactive by several mechanisms leading to the release of proinflammatory cytokines that cause further neuronal damage. We then provide updates on neuroinflammation diagnostic markers and investigational therapeutics currently in clinical trials to target neuroinflammation.
first_indexed 2024-03-09T23:45:48Z
format Article
id doaj.art-6c70caa46b644ba48f1f87120d94eb66
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T23:45:48Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6c70caa46b644ba48f1f87120d94eb662023-11-23T16:44:02ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123181057210.3390/ijms231810572Glial Cell-Mediated Neuroinflammation in Alzheimer’s DiseaseNour F. Al-Ghraiybah0Junwei Wang1Amer E. Alkhalifa2Andrew B. Roberts3Ruchika Raj4Euitaek Yang5Amal Kaddoumi6Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, 720 S Donahue Dr., Auburn, AL 36849, USADepartment of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, 720 S Donahue Dr., Auburn, AL 36849, USADepartment of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, 720 S Donahue Dr., Auburn, AL 36849, USADepartment of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, 720 S Donahue Dr., Auburn, AL 36849, USADivision of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USADepartment of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, 720 S Donahue Dr., Auburn, AL 36849, USADepartment of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, 720 S Donahue Dr., Auburn, AL 36849, USAAlzheimer’s disease (AD) is a progressive neurodegenerative disorder; it is the most common cause of dementia and has no treatment. It is characterized by two pathological hallmarks, the extracellular deposits of amyloid beta (Aβ) and the intraneuronal deposits of Neurofibrillary tangles (NFTs). Yet, those two hallmarks do not explain the full pathology seen with AD, suggesting the involvement of other mechanisms. Neuroinflammation could offer another explanation for the progression of the disease. This review provides an overview of recent advances on the role of the immune cells’ microglia and astrocytes in neuroinflammation. In AD, microglia and astrocytes become reactive by several mechanisms leading to the release of proinflammatory cytokines that cause further neuronal damage. We then provide updates on neuroinflammation diagnostic markers and investigational therapeutics currently in clinical trials to target neuroinflammation.https://www.mdpi.com/1422-0067/23/18/10572Alzheimer’s diseaseneuroinflammationmicrogliaastrocytesdiagnostic markerstherapeutics
spellingShingle Nour F. Al-Ghraiybah
Junwei Wang
Amer E. Alkhalifa
Andrew B. Roberts
Ruchika Raj
Euitaek Yang
Amal Kaddoumi
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
International Journal of Molecular Sciences
Alzheimer’s disease
neuroinflammation
microglia
astrocytes
diagnostic markers
therapeutics
title Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
title_full Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
title_fullStr Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
title_full_unstemmed Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
title_short Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
title_sort glial cell mediated neuroinflammation in alzheimer s disease
topic Alzheimer’s disease
neuroinflammation
microglia
astrocytes
diagnostic markers
therapeutics
url https://www.mdpi.com/1422-0067/23/18/10572
work_keys_str_mv AT nourfalghraiybah glialcellmediatedneuroinflammationinalzheimersdisease
AT junweiwang glialcellmediatedneuroinflammationinalzheimersdisease
AT amerealkhalifa glialcellmediatedneuroinflammationinalzheimersdisease
AT andrewbroberts glialcellmediatedneuroinflammationinalzheimersdisease
AT ruchikaraj glialcellmediatedneuroinflammationinalzheimersdisease
AT euitaekyang glialcellmediatedneuroinflammationinalzheimersdisease
AT amalkaddoumi glialcellmediatedneuroinflammationinalzheimersdisease